Crystallisation protocol for SARS-CoV-2 nsp3 macrodomain in P43

Jasmin Aschenbrenner, Peter Marples, Lizbé Koekemoer, Charlie Tomlinson, Daren Fearon

Published: 2024-08-19 DOI: 10.17504/protocols.io.e6nvw1qb2lmk/v1

Disclaimer

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Acknowledgements:

Diamond Light Source Ltd, Harwell Science and Innovation Campus, Didcot OX11 0QX, UK

Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, UK

Oxford Lab Technologies crystal shifter https://doi.org/10.1107/S2059798320014114

Abstract

The COVID-19 pandemic has demonstrated the need for novel therapeutic interventions and improved pandemic preparedness strategies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This protocol details an optimized crystallization method for the SARS-CoV-2 nsp3 macrodomain, a potential drug target. Using sitting drop vapor diffusion, we describe specific buffer conditions and procedures to consistently produce high-quality crystals suitable for XChem fragment screening. The method yields crystals that diffract to an average resolution of 1.2 Å, enabling high-resolution structural studies.

All structures solved during the development of tool compounds for the SARS-CoV-2 nsp3 macrodomain are deposited on the PDB (Group deposition: G_1002283).

Steps

SARS-CoV-2 nsp3 macrodomain expression and purification

1.

The protein usedfor crystallisation was expressed and purified using the following protocol.

SARS-CoV-2 nsp3 macrodomain expression and purification protocol for crystallization

Equipment needed

2.

Formulatrix Rock Imager (or incubator of choice)

SPT mosquito

P100 multi-channel pipette

SwissCI 3 lens plate

Crystallization experiment

3.

Protein and buffer requirements:

45µL``47mg/mL Sample

2.0mL

4.

Crystallisation screen composition:

100millimolar (mM) CHES, 9.5

30% w/v PEG 3000

Stock solutions used:

1Molarity (M) CHES adjusted to 9.5 with NaOH

50% w/v PEG 3000

Note
The crystallisation screen can be stored in a Duran bottle or aliquoted into 96 deep well block for easy dispensing into SwissCI 3 lens plates. For long-term storage keep the Crystallisation screen in the fridge at 4°C.

5.

Dispense 20µL into SwissCI 3 lens plate reservoir wells using a 100 µl multi-channel pipette.

Dispense 150nL``47mg/mL Sample to each lens using the SPT mosquito.

Dispense 150nL to each lens using the SPT mosquito.

Drop ratio: 1:1 ratio (150 nL Sample : 150 nL reservoir solution)

Final drop volume: 300 nl

6.

Incubate at 20°C for 48h 0m 0s in Formulatrix Rock Imager.

Imaging Schedule : The first images are taken after 12 h and the imaging schedule follows a Fibonacci sequence of days for further collections.

7.

Crystal form after ~24 h.

Citation
The crystals reach their maximum size after 48 h.Crystals typically form as single crystals.Morphology: typically large cubes or rectangles.Size: ~300 μm in length and ~150 μm in width, depth of the crystals is ~100 μmAppearance : large crystal chunks.Average resolution: 1.2 ÅSpace group: P43Unit cell: 89 Å, 89 Å, 39 Å 90.00°, 90.00°, 90.00°
An example of a drop containing SARS-CoV-2 nsp3 macrodomain crystals
An example of a drop containing SARS-CoV-2 nsp3 macrodomain crystals

Data Collection at Synchrotron

8.

Diamond Light Source

Unattended Data Collection (UDC)

Data Collection Temperature: 100K

Detector: DECTRIS EIGER2 X 9M

Beamline: I04-1

Wavelength: 0.9212 Å

Resolution (Å): 1.62

Beam Size (μm): 60 X 50

Number of images: 3600

Oscillation: 0.10°

Exposure (s): 0.0020

Transmission (%): 100

Flux (ph/s): 3.80e+12

推荐阅读

Nature Protocols
Protocols IO
Current Protocols
扫码咨询